Bioengineering and translational medicine
Is Bioengineering & Translational Medicine a good journal?
Bioengineering and Translational Medicine is the 7th out of 504 Biotechnology journals.
This means the journal is among the top 2% in the sub-discipline of Biotechnology..
What is the impact factor of Bioengineering and Translational Medicine journal?
Impact Score 2022 of Bioengineering and Translational Medicine is 7.61.
If a similar upward trend continues, IS may increase in 2023 as well..
What is the impact factor of Bioengineering and Translational Medicine?
2020 marks an important year in the evolution of BioTM.
We received our first impact factor of 6.091 this year.
This is a massive accomplishment for all stakeholders of the journal.
The journal was formally launched in 2015 and we published our first issue in 2016..
What is the ranking of Bioengineering and Translational Medicine?
Based on the Scopus data, the SCImago Journal Rank (SJR) of Bioengineering and Translational Medicine is 1.484..
What means Translational Medicine?
Translational medicine (also referred to as translational science) is a discipline within biomedical and public health research that aims to improve the health of individuals and the community by “translating” findings into diagnostic tools, medicines, procedures, policies and education. (.
- Based on the Scopus data, the SCImago Journal Rank (SJR) of Bioengineering and Translational Medicine is 1.484.
- Bioengineering & Translational Medicine is an official quarterly, peer-reviewed, online, open access journal of the American Institute of Chemical Engineers (AIChE) and its technological community, the Society for Biological Engineering (SBE), published on our behalf by John Wiley & Sons.
- Prominent biomedical engineering applications include the development of biocompatible prostheses, various diagnostic and therapeutic medical devices ranging from clinical equipment to micro-implants, common imaging equipment such as MRIs and EKG/ECGs, regenerative tissue growth, pharmaceutical drugs and therapeutic
Bioengineering & Translational Medicine is a peer-reviewed, online, open access journal focused on the fundamental ways chemical and biological engineering Author GuidelinesJournal MetricsOpen AccessEditorial Board
Bioengineering & Translational Medicine is a peer-reviewed, online, open access journal focused on the fundamental ways chemical and biological engineering Author GuidelinesJournal MetricsOpen AccessOverview
Bioengineering & Translational Medicine is focused on the fundamental ways chemical and biological engineering approaches drive and provide innovative technologies and solutions that impact clinical practice and/or commercial healthcare products.
Journal Overview. Bioengineering & Translational Medicine is a peer-reviewed, online, open access journal focused on the fundamental ways chemical and Author GuidelinesJournal MetricsOpen AccessOverview
Journal Overview. Bioengineering & Translational Medicine is a peer-reviewed, online, open access journal focused on the fundamental ways chemical and Author GuidelinesJournal MetricsOpen AccessOverview
An NIH agency of the US Department of Health and Human Services
The National Center for Advancing Translational Sciences (NCATS) was established on December 23, 2011 and is located in Bethesda, Maryland.
NCATS is one of 27 institutes and centers of the U.S.
National Institutes of Health (NIH), an agency of the U.S.
Department of Health and Human Services.
The mission of NCATS is to transform scientific discoveries into new treatments and cures for disease that can be delivered faster to patients.
The budget provided to NCATS for fiscal year 2018 is $557,373,000.
Conversion to apply basic biomedical science to clinical practice
Translational medicine develops the clinical practice applications of the basic science aspects of the biomedical sciences; that is, it translates basic science to applied science in medical practice.
It is defined by the European Society for Translational Medicine as an interdisciplinary branch of the biomedical field supported by three main pillars: benchside, bedside, and community.
The goal of translational medicine is to combine disciplines, resources, expertise, and techniques within these pillars to promote enhancements in prevention, diagnosis, and therapies.
Accordingly, translational medicine is a highly interdisciplinary field, the primary goal of which is to coalesce assets of various natures within the individual pillars in order to improve the global healthcare system significantly.
An NIH agency of the US Department of Health and Human Services
The National Center for Advancing Translational Sciences (NCATS) was established on December 23, 2011 and is located in Bethesda, Maryland.
NCATS is one of 27 institutes and centers of the U.
S.
National Institutes of Health (NIH), an agency of the U.
S.
Department of Health and Human Services.
The mission of NCATS is to transform scientific discoveries into new treatments and cures for disease that can be delivered faster to patients.
The budget provided to NCATS for fiscal year 2018 is $557,373,000.
Conversion to apply basic biomedical science to clinical practice
Translational medicine develops the clinical practice applications of the basic science aspects of the biomedical sciences; that is, it translates basic science to applied science in medical practice.
It is defined by the European Society for Translational Medicine as an interdisciplinary branch of the biomedical field supported by three main pillars: benchside, bedside, and community.
The goal of translational medicine is to combine disciplines, resources, expertise, and techniques within these pillars to promote enhancements in prevention, diagnosis, and therapies.
Accordingly, translational medicine is a highly interdisciplinary field, the primary goal of which is to coalesce assets of various natures within the individual pillars in order to improve the global healthcare system significantly.
